Xiaflex Plus Testosterone Treatment Pilot Study Protocol A Six-month, Pilot Project of Testosterone Treatment in Subjects Who Are Undergoing Xiaflex Therapy for the Treatment of Peyronie's Disease
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Collagenase clostridium histolyticum (Primary) ; Testosterone undecanoate (Primary)
- Indications Peyronie's disease
- Focus Therapeutic Use
Most Recent Events
- 30 Dec 2021 Status changed from active, no longer recruiting to completed.
- 31 Aug 2020 Planned End Date changed from 1 Jul 2020 to 1 Feb 2021.
- 31 Aug 2020 Planned primary completion date changed from 1 Jul 2020 to 1 Feb 2021.